KRIS HOUSER: Open Payments
NPI 1992798284 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,553 in 119 payments from 14 companies in 2025. Trend: 2023 $3,566 · 2024 $2,313 · 2025 $2,553
Food & beverage: $2,553
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 20 | $454 |
| Axsome Therapeutics, Inc. | 22 | $352 |
| ABBVIE INC. | 16 | $345 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $336 |
| Alkermes, Inc. | 10 | $323 |
| Otsuka America Pharmaceutical, Inc. | 14 | $231 |
| Vanda Pharmaceuticals Inc. | 8 | $155 |
| Janssen Pharmaceuticals, Inc | 4 | $101 |
| Lundbeck LLC | 4 | $74 |
| Teva Pharmaceuticals USA, Inc. | 3 | $69 |
Products named: INGREZZA, Auvelity, VRAYLAR, CAPLYTA, REXULTI, LYBALVI, FANAPT, SPRAVATO.
Industry payments across TN — which companies pay providers there.
